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Abstract
Understanding the role of natural killer (NK) cells in human disease pathogenesis is crucial and
necessitates study of patient samples directly ex vivo. Manipulation of whole blood by density
gradient centrifugation or delays in sample processing due to shipping, however, may lead to
artifactual changes in immune response measures. Here, we assessed the impact of density
gradient centrifugation and delayed processing of both whole blood and peripheral blood
mononuclear cells (PBMC) at multiple timepoints (2–24 hrs) on flow cytometric measures of NK
cell frequency, activation status, chemokine receptor expression, and effector functions. We found
that density gradient centrifugation activated NK cells and modified chemokine receptor
expression. Delays in processing beyond 8 hours activated NK cells in PBMC but not in whole
blood. Likewise, processing delays decreased chemokine receptor (CCR4 and CCR7) expression
in both PBMC and whole blood. Finally, delays in processing PBMC were associated with a
decreased ability of NK cells to degranulate (as measured by CD107a expression) or secrete
cytokines (IFN-γ and TNF-α). In summary, our findings suggest that density gradient
centrifugation and delayed processing of PBMC can alter measures of clinically relevant NK cell
characteristics including effector functions; and therefore should be taken into account in
designing clinical research studies.
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Quantitative measures of natural killer (NK) cell frequency, activation, trafficking potential
and effector functions are important to consider in clinical research because these measures
are associated with reduced disease pathogenesis of viral and neoplastic diseases (Orange
and Ballas, 2006). Nonetheless, the study of human NK cells from diseased patients directly
ex vivo has two important challenges. Firstly, in multicenter trials and developing country
settings the time from venipuncture to sample processing may be prolonged due to long
transport times to a central research laboratory. Secondly, there is little consensus on
whether peripheral blood mononuclear cells (PBMC) and whole blood are equivalent sample
types for studies of NK cells. These are important considerations in designing clinical
studies because it is often unfeasible to isolate PBMCs from whole blood in a timely
manner. Thus, delays in processing and the type of starting sample may affect measurements
of NK cell characteristics; however, their impact has not been well characterized.
Previous studies have shown that PBMC prepared by density gradient centrifugation may
not be equivalent to whole blood for measuring some leukocyte parameters. Specifically,
density gradient centrifugation altered the proportion of T-cells expressing cytokine
receptors (varying by specific receptor), and increased the proportion of T-cells expressing
adhesion molecules (Renzi and Ginns, 1987; Tamul et al., 1995; Lin et al., 2002; Berhanu et
al., 2003). Likewise, delays in the time from venipuncture to sample processing altered the
phenotype or functional responses of leukocytes. Ekong and colleagues found that delays in
processing PBMC reduced T-cell frequencies (Ekong et al., 1993) and others have reported
impaired T-cell responses as measured by cytokine secretion or proliferation (Betensky et
al., 2000; Bull et al., 2007; Kierstead et al., 2007; McKenna et al., 2009; Weinberg et al.,
2009). As a potential mechanism to explain these findings, McKenna and colleagues
(McKenna et al., 2009) recently demonstrated that delayed processing of blood increased the
frequency of activated CD11bpos and CD15pos granulocytes, and that these leukocytes
inhibited T-cell responses. Furthermore, the induction of changes in activation and
functional responses is not confined to T-cells. Delayed processing also reduced monocyte
and dendritic cell responses to Toll like receptor ligands (Meier et al., 2008). Thus, density
gradient centrifugation and delayed processing of blood or PBMC can affect important
leukocyte parameters; however, their effects on NK cells have not been well described.
Here we report the impact of density gradient centrifugation and delayed processing on NK
cell frequency, activation, chemokine receptor expression (as markers of trafficking
potential) and effector function in whole blood and PBMC at multiple timepoints (2–24
hrs.). Our results suggest that while delayed sample processing does not affect NK cell
frequencies, both delayed processing and density gradient centrifugation alter chemokine
receptor expression and in vitro effector functions. It is therefore crucial to take these factors
into account in designing clinical studies that measure innate immune responses.
2. Materials and Methods
2.1 Study Subjects
Blood samples from a total of 11 adult (20–31 years) females enrolled in an observational
cohort of healthy women at Edendale Hospital (a district level hospital in Pietermaritzburg,
KwaZulu Natal, South Africa) were included in these studies. Participantsgave informed
consent. The University of KwaZulu Natal Biomedical Research Ethics Committee
(E118/06), the Edendale Hospital ethics committee and the Massachusetts General Hospital
Internal Review Board approved this study.
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2.2 Assessment of NK cell frequency, activation and chemokine receptor expression in
whole blood and PBMC
A total of 34 mls of blood was drawn into four acid citrate dextrose (ACD) tubes (BD
Biosciences), transported by vehicle at atmospheric temperature (23–25°C) to the research
laboratory in Durban, South Africa, and kept at ambient room temperature (20–23°C) until
being processed. All donors were bled within 15 minutes of each other and all samples
reached the laboratory within two-hours of venipuncture. At 2, 8,16 and 24 hours after
venipuncture, PBMC were prepared by density gradient centrifugation using Histopaque
1077 (Sigma, St Louis, MO) as per the manufacturers protocol. Whole blood (processed at 2
and 24 hours after venipuncture) and PBMC (processed at 2, 8,16 and 24 hours after
venipuncture) were stained using separate panels of antibodies to measure NK cell
frequency, activation and chemokine receptor expression by multiparametric flow cytometry
on an LSRII flow cytometer (BD Biosciences).
For whole blood staining, 300μl whole blood was stained with three separate antibody
cocktails for 20 minutes at 4°C in the dark. Subsequently, red blood cells were lysed with
1ml Versalyse Lysing Solution (Beckman Coulter, France) and the cells were concomitantly
fixed with IOTest3 (Beckman Coulter, France), per the manufacturers protocol for the
concomitant ‘Fix and Lyse’ procedure.
For PBMC staining, two million PBMC per staining condition were washed and
resuspended in 50μl of calcium and magnesium free Dulbecco’s phosphate buffered saline
(DPBS) (Invitrogen). The cells were then stained for 20 minutes with LIVE/DEAD fixable
aqua dead cell stain (Invitrogen) per the manufacturers instructions. Next, the samples were
washed, resuspended in DPBS, and stained with each of three separate antibody cocktails for
20 minutes at 4°C in the dark. The cells were then washed twice to remove excess antibody
and fixed with 1% paraformaldehyde (Sigma, St Louis, MO) before being acquired on the
LSRII.
Antibody cocktails for staining panels—All antibodies were purchased from BD
Biosciences unless otherwise indicated. The antibody cocktails consisted of anti-CD3
Qdot-605 (Invitrogen) or anti-CD4 Qdot-605 (Invitrogen), anti-CD8 Qdot-655 (Invitrogen),
anti-CD14 Pacific Orange (Invitrogen), anti-CD19 Pacific Orange (Invitrogen), anti-CD16
Pacific Blue (Invitrogen), anti-CD38 PE-Cy7 or anti-CCR7 PE-Cy7, anti-CD56 PE-Cy5,
anti-CD69 FITC or anti-CCR4 FITC or anti-NKp46, anti-HLA-DR APC-H7, anti-CD69
APC or anti-CCR5 APC, anti-CD45 AlexaFluor 700 (Invitrogen)-for whole blood staining
only or anti-CD3 AlexaFluor 700 (Invitrogen) conjugated antibodies. All antibodies were
titrated to determine optimal saturating concentrations for staining.
2.3 Stimulation of PBMC for the assessment of NK cell degranulation and intracellular
cytokine expression
One million PBMC were cultured in 1 ml of RPMI 1640 (supplemented with 10% fetal calf
serum and 1% Penicillin/streptomycin), 0.5 μl Golgistop (BD Biosciences), 5μg/ml
brefaldin A (SIgma, St Louis, MO), and simultaneously stained with 10μl anti-CD107a PE-
Cy5 (BD Pharmingen). After 4 hours, Phorbol-12-myristate-13- acetate (PMA) (Sigma, St
Louis, MO) plus Ionomycin (Sigma, St Louis, MO) were added at 1μg/ml and 0.5 μg/ml,
respectively, and incubation continued for a further 2 hours at 37°C, 5% CO2. After a total
of 6 hours of incubation cells were washed twice with DPBS and stained for 20 minutes
with LIVE/DEAD fixable aqua dead cell stain (Invitrogen) per the manufacturers
instructions. After being washed twice, cells were surface stained for 20 minutes at 4°C in
the dark with anti-CD3 AlexaFluor 700 (Invitrogen), anti-CD14 Pacific Orange (Invitrogen),
anti-CD16 Pacific Blue (Invitrogen) and anti-CD56 PE (BD Biosciences) conjugated
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antibodies. Next, the cells were washed with DPBS and fixed with 100μl Fix&Perm Reagent
A (Invitrogen) for 20 minutes at room temperature. Following fixation, cells were washed
and incubated in 100μl Fix&Perm Reagent B (Invitrogen) containing anti-Interferon-γ PE-
Cy7 and anti-tumour necrosis factor-α FITC conjugated antibodies, for a further 20 minutes
at 4°C in the dark. Finally, cells were washed, resuspended in DPBS and 500,000–1000,000
events were acquired on the LSRII. In addition, eight-peak mid-range beads (BD
Biosciences) were used to standardize instrument settings on the LSRII between each run.
2.4 Analysis of flow cytometric data
The proportions of activated, chemokine receptor-expressing, degranulating, or cytokine
secreting NK cells were analyzed using Flowjo (v9.0.1, Treestar). Phenotypically, NK cells
were defined as aqua viability dye negative (live), CD3neg, CD14neg, CD19neg, CD16pos
and/or CD56pos. In the gating strategy, gates were standardized using fluorescence minus
one (FMO) controls. Time and singlet gates were included. We assessed both proportions of
NK cells and levels of marker expression as measured by mean fluorescence intensity
(MFI). All measures of frequency and activation were done in duplicate using independent
flow cytometric panels. Means for duplicate measures have been indicated.
Data were summarized and statistical tests performed in Graphpad Prism (v5, Graphpad
Prism Inc.). Paired t-tests were applied to assess statistical significance of differences
between different timepoints, or between different sample-types from an individual. A
repeated measures ANOVA was used to assess statistical significance of differences
between several (>2) timepoints. To test for linear trend, a test for trend was calculated, and
where relevant we report the p value testing for nonlinear variation after correcting for a
linear trend. P-values were not corrected for comparisons that we defined a priori.
3. Results
Previous studies have shown that delays in blood sample processing or the process of
isolating PBMC may alter phenotypes or functions of leukocytes(Renzi and Ginns, 1987;
Tamul et al., 1995; Lin et al., 2002; Berhanu et al., 2003)(Betensky et al., 2000; Bull et al.,
2007; Kierstead et al., 2007; McKenna et al., 2009; Weinberg et al., 2009). To quantify the
impact of density gradient centrifugation and delayed processing on NK cells, we evaluated
whole blood and PBMC samples from five healthy adults processed at different timepoints
after venipuncture(Fig. 1a). These timepoints corresponded to processing of samples
immediately on receipt (2 hrs), at the end of a routine working day (8 hrs), after an overnight
rest (16 hrs), or one full day later (24 hrs). Using multiparameter flow cytometry, NK cells
were defined based on the absence of T-cell, monocyte, or B-cell markers (CD3, CD14, and
CD19, respectively), and the presence of CD16 and/or CD56 (Fig. 1b). In addition, non-
viable cells and cell doublets were excluded from analysis.
3.1 Frequencies of NK cells are not significantly affected by delays in blood sample
processing
Following delays in the preparation of PBMC from whole blood at 2, 8, 16, and 24 hours
post-venipuncture, the frequencies of NK cells remained unchanged; however, there was a
weak trend towards reduced frequencies of NK cells with time (repeated measure ANOVA
p=0.147, post test for trend p=0.031, r2=0.1) (Fig 2a). Likewise, the frequencies of NK cells,
as a proportion of all CD45pos cells in whole blood, were similar in blood processed at 2
hours and 24 hours post venipuncture (means of 10.3% and 9.1% respectively), (Fig 2b).
Whole blood was not assessed at 8 or 16 hours post venipuncture due to limited sample
availability. Overall, we found no change in NK cell frequencies over time in both whole
blood and PBMC. Based on previous reports of lymphocyte alterations attributed to sample
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processing (Renzi and Ginns, 1987;Tamul et al., 1995;Lin et al., 2002;Berhanu et al., 2003),
we next wanted to assess whether density gradient centrifugation affected the quality of the
NK cells.
3.2 Density gradient centrifugation alters NK cell activation and the expression of
chemokine receptors
Using multi-parametric flow cytometry, we measured the activation status of NK cells ex
vivoand the expression of selected chemokine receptors in the samples processed from the
same five donors used previously (Fig 3). First, to assess NK cell activation we quantified
the expression of CD38, CD69, HLA-DR and NKp46 on NK cells in whole blood vs.
PBMC prepared 2 hrs after venipuncture (Fig 3a). We chose these markers for two reasons.
On NK cells, the levels of CD69 and HLA-DR expression have previously been used as
surrogates for acute and chronic activation, respectively (Ziegler et al., 1993;Fogli et al.,
2004;Ravet et al., 2007). Secondly, we and other investigators have reported a loss of
NKp46 expression on activated NK cells (Wong et al.; Fogli et al., 2008); thus, the level of
NKp46 expression may also serve as a surrogate measure of NK cell activation.
The proportions of NK cells expressing CD69, a marker of acute activation, roughly doubled
from 0.36% in whole blood to 0.85%, following density gradient centrifugation (p=0.034)
(Fig 3a). There was, however, no change in the proportions of NK cells expressing HLA-
DR. This increase in CD69 expression was not associated with a significant decrease in the
proportion of NKp46 expressing NK cells (Fig 3a). In addition, we observed a modest, but
statistically significant decrease in the proportion of NK cells expressing CD38 following
density gradient centrifugation (69.78% in whole blood vs. 65.5% in PBMC, p=0.026).
These results suggest that NK cells may be acutely activated by density gradient
centrifugation; however, the degree of this effect was small.
Unlike some activation markers, chemokine receptors undergo rapid internalization and
endocytic recycling, and therefore, have high rates of turnover at the cell surface (Neel et al.,
2005). We therefore predicted that the cell surface expression of chemokine receptors might
be more susceptible to the effects of density gradient centrifugation than activation markers.
To test this hypothesis we quantified the expression of two chemokine receptors on NK cells
in whole blood vs. PBMC (Fig 3b). We chose to specifically assess CCR4 and CCR7since
both are expressed on NK cells and have ligands that are critical for trafficking to the skin
and lymph nodes, respectively (Berahovich et al., 2006). With density gradient
centrifugation we found a substantial increase in the average proportion of CCR4-expressing
NK cells (10.5% in whole blood vs. 50.9% in PBMC, p<0.001) (Fig 3b). However, we
observed a tendency for proportionally fewer NK cells expressing CCR7 (37.5% in whole
blood vs. 21.8% in PBMC) following density gradient centrifugation, but this difference was
not statistically significant (p=0.13). Consistent with our findings of increased proportions of
CCR4-expressing NK cells, we also observed a tendency towards increased surface
expression of CCR4 following density gradient centrifugation (2.7 log10 MFI in whole
blood vs. 3.24 log10 MFI in PBMC, p=0.077). Likewise, we observed a statistically
significant reduction of CCR7 expression on NK cells following density gradient
centrifugation (3.1 log10 MFI in whole blood vs. 2.61 log10 MFI in PBMC, p=0.014)
(supplementary table 1). Taken together, these data suggest that density gradient
centrifugation marginally alters the activation status of NK cells, but dramatically alters their
expression of chemokine receptors such as CCR4.
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3.3 Processing of blood beyond 8 hrs after venipuncture results in activation of NK cells
and alteration of chemokine receptor expression
Based on our findings of changes in activation and chemokine receptor expression profiles
following density gradient centrifugation, we next wanted to know how delays in
processing, affected these parameters. Hence, we measured these parameters on NK cells in
PBMC at 2, 8, 16 and 24 hrs after venipuncture and in whole blood at 2 and 24 hrs after
venipuncture (Fig 4).
Similar to our previous findings, we observed changes in the expression of activation
markers and chemokine receptors. We found no significant change in the proportions of NK
cells in PBMC expressing either CD38 or HLA-DR with delays in processing (Fig 4a).
However, we observed greater proportions of NK cells expressing CD69 (p=0.027) and
lower proportions of NK cells expressing NKp46 in PBMC processed more than 8 hrs after
venipuncture (p<0.001) (Fig 4a). The magnitude of these effects was greater than the
comparison between whole blood and PBMC. Consistent with these changes, we also noted
an increase in the MFI of CD69 and decrease in the MFI of NKp46 (supplementary table 1).
Thus, delays in processing activated NK cells in PBMC and substantially reduced the
proportions of NK cells expressing either CCR4 (p<0.0001) or CCR7 (p=0.0008) (Fig. 4b).
However, these decreases were only noted in PBMC processed more than 8 hrs after
venipuncture. Consistent with these findings, over time we also noted lower MFIs for both
chemokine receptors (supplementary table 1). Finally, to address whether these effects were
limited to NK cells we further analyzed measures of activation and chemokine receptor
expression on T-cells in the same samples. Similar to our findings from NK cells, we
observed a trend of increased activation for both CD4 and CD8 T-cells as measured by
CD38 (supplementary Fig. 1), We also observed proportionally fewer CCR4, CCR5 and
CCR7-expressing T-cells over time (supplementary Fig. 1). Thus the changes we observed
were consistent for both T-cells and NK cells.
Likewise, in whole blood stained at 2 and 24 hrs after venipuncture, we observed no change
in the proportions of NK cells expressing CD38, HLA-DR or CD69 (Fig 4c). In contrast, we
found a decrease in the proportion of NKp46-expressing NK cells (42.6% at 2 hrs vs.
28.06% at 24 hrs, p=0.009) (Fig 4c). These findings were consistent with decreased surface
densities of these receptors as measured by MFI (supplementary table 1). Furthermore, we
discovered a dramatic loss of CCR7 staining on NK cells in whole blood stained at 24 hrs
after venipuncture (37.5% at 2 hrs vs. 0.25% at 24 hrs, p=0.008), which was substantiated by
a concomitant decline in the levels of CCR7 expression (supplementary table 1). In contrast,
we found no difference in the proportions of CCR4-expressing NK cells (10.5% at 2 hrs vs.
6.8% at 24 hrs, p=0.11) (fig. 4d). Similarly, MFIs for CCR4 were only marginally lower at
24 hrs (2.70 MFI (log10) vs. 2.61 at 2 hrs. and 24 hrs., respectively, p=0.04; supplementary
table 1). Taken together, these data suggest that delayed processing of whole blood
minimally impacted NK cell activation status, but profoundly diminished expression of
some chemokine receptors. Notably, these effects were more apparent with PBMC than
whole blood.
3.4 Delayed processing of blood decreases functional responses of NK cells following in
vitro stimulation
The significant loss of NKp46 expression in PBMC over time suggested that delayed
processing could alter functional responses. Previously, De Maria and colleagues
demonstrated diminished functional responses by NK cells with lower NKp46 expression
(De Maria et al., 2003). To assess whether the changes we observed were accompanied by
alterations in NK cell effector functions, we measured the impact of delayed sample
processing on degranulation and cytokine secretion following in vitro stimulation (Fig 5).
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For these assays we selected 6 additional healthy donors. We used PMA plus Ionomycin to
stimulate NK cells in PBMC prepared 2, 16 and 24 hrs after venipuncture (stimulation of
PBMC prepared at 8 hrs was not performed due to insufficient sample availability). We
quantified functional responses using flow cytometry by gating on NK cells expressing
CD107a, a surrogate for degranulation (Alter et al., 2004), and interferon-γ (IFN-γ) or tumor
necrosis factor-α (TNF-α).
Following in vitro stimulation we observed a significant reduction in both NK cell
degranulation and cytokine secretion with delays in processing that was most marked with
delays of greater than16 hours (Fig 5). The proportion of NK cells expressing CD107a
correlated with the proportion expressing IFN-γ (p=0.002, r2=0.59), but not with the
proportion expressing TNF-α. However, we noted a positive correlation between proportions
of NK cells expressing IFN-γ and TNF-α (p=0.008, r2=0.37). These findings suggest that
delays in processing of PBMCs significantly impair NK cell cytokine secretion and
degranulation.
4. Discussion
In clinical studies there are few standardized methods for assessing NK cell parameters,
including their frequency, activation, chemokine receptor expression, or effector functions.
Some investigators have reported marked differences in antiviral responses mediated by NK
cells using fresh whole blood vs. PBMC prepared by density gradient centrifugation
(Tiemessen et al., 2009). This finding along with previous reports of leukocyte alterations
with density gradient centrifugation(Renzi and Ginns, 1987; Tamul et al., 1995; Lin et al.,
2002; Berhanu et al., 2003) suggest that these factors are important to consider in designing
studies using blood samples. Our work further extends these findings by quantifying the
impact of sample type and processing delays on NK cells. For the first time we demonstrate
that delays in processing alter chemokine receptor expression on NK cells and decrease NK
cell functional responses.
Our overall aim was to assess the impact of density gradient centrifugation and delayed
processing on NK cell frequency, activation, chemokine receptor expression and effector
function. We found that NK cell frequencies in whole blood and PBMC were unaffected by
delays in processing up to 24hrs. This is not unexpected since NK cells have a half-life of
about 7–10 days in vivo (Zhang et al., 2007) so they would not be predicted to die or
proliferate dramatically over a 24-hour period ex vivo. We also found that density gradient
centrifugation acutely activated NK cells; however the magnitude of this change was
relatively small and most likely biologically insignificant. In comparison, much greater
alterations in acute activation of NK cells occur following vaccination (Horowitz et al.,
2010). Similarly, we found slight differences in CD38 expression due to sample processing
although the function of CD38 on NK cells remains undetermined. By using consistent
sample processing methods these differences may be taken into account.
In contrast, the effects of density gradient centrifugation on chemokine receptor expression
are dramatic, particularly for CCR4. Our results suggest that density gradient enhances the
detection of CCR4 on NK cells. One possible explanation for this finding is that the reagents
used in density gradient centrifugation may stabilize the cell-surface expression of highly
labile chemokine receptors, Similar reported effects of enhanced chemokine receptor
expression on T-cells further support this hypothesis(Berhanu et al., 2003). Thus, our results
suggest that chemokine receptor expression is not comparable between NK cells in whole
blood and PBMC. Using different sample types for comparisons may yield inconsistent
results.
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In addition, delays in processing for more than 8 hours dramatically affect chemokine
receptor expression on NK cells. This finding is consistent with similar reported effects on
T-cells (Nicholson et al., 1984; Ekong et al., 1993; Betensky et al., 2000; Lin et al., 2002;
Berhanu et al., 2003; Bull et al., 2007; Meier et al., 2008; McKenna et al., 2009). With NK
cells, the expression of both CCR4 and CCR7 diminishesover time. This effect on CCR4
expression is most notable in PBMC; whereas, the effect on CCR7 expression is most
notable in whole blood. Taken together, our findings imply that clinical samples must be
analyzed within 8 hours of collection to reliably assess chemokine receptor expression on
NK cells. Such guidelines are useful considerations for the design and implementation of
clinical studies that quantify NK cell subsets.
Similarly, we found that delays of more than 16 hours significantly impaired degranulation
and cytokine secretion by NK cells. These findings are consistent with previously described
changes in functional responses by T-cells, dendritic cells and monocytes(McKenna et al.,
2009; Meier et al., 2008). Notably delays of more than 8 hours severely impair dendritic cell
and monocyte cytokine secretion following in vitro stimulation (Meier, 2008 #13;). Thus, 8
hours is a general benchmark for quality control assessment in deciding the usability of
blood samples for measuring NK cell functional responses. While the mechanisms
underlying dysfunction remain unknown, we speculate that, as previously shown for T-cells,
the expansion of activated CD11bpos and CD15pos granulocytes may dampen NK cell
responses through changes in the cytokine milieu (McKenna et al., 2009). Alternatively,
intracellular signaling components required for robust responses may become depleted over
time ex vivo. To understand the basis of this impairment further investigations are
warranted; however, it is apparent that the time from sample collection to assay
implementation is a critical consideration in obtaining valid results. This study extends the
work of previous studies by providing an estimate of time for the assessment of NK cell
parameters ex vivo. Samples that are analyzed greater than 16 hours after collection may
yield deficient NK cell responses. Since we did not assess timepoints between 2and16 hours
we cannot provide a more accurate estimate of a suitable limit on sample transport to permit
functional analyses but based on the findings reported here, and those of others(McKenna et
al., 2009; Meier et al., 2008), we believe 8 hours is a reasonable benchmark.
A few limitations of our study warrant mention. Firstly, our conclusions are limited to blood
samples from adults. Lin and colleagues have reported different effects of sample processing
variation using blood samples from young children and infants (Lin et al., 2002).Secondly,
for these assays we used blood drawn on ACD treated tubes. It is plausible that blood drawn
into ethylenediamine tetra-acetic acid (EDTA) tubes may yield different results, particularly
for measures of activation. EDTA chelates divalent cations that are crucial for activation
processes and thus may reduce the effects of ex vivo activation. Finally, since our cohort was
small, there is risk of a type II error in interpretation of the data; hence findings of no effect
should be interpreted with caution, and attention to possible trends should be made.
6. Conclusion
Based on these findings, interpretation of studies using NK cells processed after delays of
greater than 8 hours or after density gradient centrifugation warrants careful consideration.
In particular, variations in sample processing time and/or methods have the greatest impact
on NK cell chemokine receptor expression and in vitro functional responses. Thus, where
possible, delays in processing should be avoided, and careful attention should be made in the
selection of NK cell parameters that are least affected by these variables in the assessment of
clinical samples.
Naranbhai et al. Page 8














Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
This study was supported by the South African HIV/AIDS Research Platform (SHARP), the MGH Physician
Scientist Development Award (W.H.C.), and in part by NIH-FIC K01 grant (K01-TW00703-01A1) to W.H.C. We
thank LIFELab and the Columbia University-South Africa Fogarty AITRP for supporting V.N. M.A. is a
Distinguished Clinical Scientist of the Doris Duke Charitable Foundation.
References
Alter G, Malenfant JM, Altfeld M. CD107a as a functional marker for the identification of natural
killer cell activity. J Immunol Methods 2004;294:15–22. [PubMed: 15604012]
Berahovich RD, Lai NL, Wei Z, Lanier LL, Schall TJ. Evidence for NK cell subsets based on
chemokine receptor expression. J Immunol 2006;177:7833–40. [PubMed: 17114454]
Berhanu D, Mortari F, De Rosa SC, Roederer M. Optimized lymphocyte isolation methods for analysis
of chemokine receptor expression. J Immunol Methods 2003;279:199–207. [PubMed: 12969561]
Betensky RA, Connick E, Devers J, Landay AL, Nokta M, Plaeger S, Rosenblatt H, Schmitz JL,
Valentine F, Wara D, Weinberg A, Lederman HM. Shipment impairs lymphocyte proliferative
responses to microbial antigens. Clin Diagn Lab Immunol 2000;7:759–63. [PubMed: 10973450]
Bull M, Lee D, Stucky J, Chiu YL, Rubin A, Horton H, McElrath MJ. Defining blood processing
parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials.
J Immunol Methods 2007;322:57–69. [PubMed: 17382342]
De Maria A, Fogli M, Costa P, Murdaca G, Puppo F, Mavilio D, Moretta A, Moretta L. The impaired
NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface
expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur J Immunol
2003;33:2410–8. [PubMed: 12938217]
Ekong T, Kupek E, Hill A, Clark C, Davies A, Pinching A. Technical influences on
immunophenotyping by flow cytometry. The effect of time and temperature of storage on the
viability of lymphocyte subsets. J Immunol Methods 1993;164:263–73. [PubMed: 8370932]
Fogli M, Costa P, Murdaca G, Setti M, Mingari MC, Moretta L, Moretta A, De Maria A. Significant
NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1-
infected patients. Eur J Immunol 2004;34:2313–21. [PubMed: 15259029]
Fogli M, Mavilio D, Brunetta E, Varchetta S, Ata K, Roby G, Kovacs C, Follmann D, Pende D, Ward
J, Barker E, Marcenaro E, Moretta A, Fauci AS. Lysis of endogenously infected CD4+ T cell blasts
by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals. PLoS
Pathog 2008;4:e1000101. [PubMed: 18617991]
Horowitz A, Behrens RH, Okell L, Fooks AR, Riley EM. NK cells as effectors of acquired immune
responses: effector CD4(+) T cell-dependent activation of NK cells following vaccination. J
Immunol 2010;185:2808–18. [PubMed: 20679529]
Kierstead LS, Dubey S, Meyer B, Tobery TW, Mogg R, Fernandez VR, Long R, Guan L, Gaunt C,
Collins K, Sykes KJ, Mehrotra DV, Chirmule N, Shiver JW, Casimiro DR. Enhanced rates and
magnitude of immune responses detected against an HIV vaccine: effect of using an optimized
process for isolating PBMC. AIDS Res Hum Retroviruses 2007;23:86–92. [PubMed: 17263637]
Lin SJ, Chao HC, Yan DC, Huang YJ. Expression of adhesion molecules on T lymphocytes in young
children and infants--a comparative study using whole blood lysis or density gradient separation.
Clin Lab Haematol 2002;24:353–9. [PubMed: 12452816]
McKenna KC, Beatty KM, Vicetti Miguel R, Bilonick RA. Delayed processing of blood increases the
frequency of activated CD11b+ CD15+ granulocytes which inhibit T cell function. J Immunol
Methods 2009;341:68–75. [PubMed: 19041316]
Meier A, Fisher A, Sidhu HK, Chang JJ, Wen TF, Streeck H, Alter G, Silvestri G, Altfeld M. Rapid
loss of dendritic cell and monocyte responses to TLR ligands following venipuncture. J Immunol
Methods 2008;339:132–40. [PubMed: 18848564]
Naranbhai et al. Page 9













Neel NF, Schutyser E, Sai J, Fan GH, Richmond A. Chemokine receptor internalization and
intracellular trafficking. Cytokine Growth Factor Rev 2005;16:637–58. [PubMed: 15998596]
Nicholson JK, Jones BM, Cross GD, McDougal JS. Comparison of T and B cell analyses on fresh and
aged blood. J Immunol Methods 1984;73:29–40. [PubMed: 6333461]
Orange JS, Ballas ZK. Natural killer cells in human health and disease. Clin Immunol 2006;118:1–10.
[PubMed: 16337194]
Ravet S, Scott-Algara D, Bonnet E, Tran HK, Tran T, Nguyen N, Truong LX, Theodorou I, Barre-
Sinoussi F, Pancino G, Paul P. Distinctive NK-cell receptor repertoires sustain high-level
constitutive NK-cell activation in HIV-exposed uninfected individuals. Blood 2007;109:4296–305.
[PubMed: 17272507]
Renzi P, Ginns LC. Analysis of T cell subsets in normal adults. Comparison of whole blood lysis
technique to Ficoll-Hypaque separation by flow cytometry. J Immunol Methods 1987;98:53–6.
[PubMed: 2951443]
Tamul KR, Schmitz JL, Kane K, Folds JD. Comparison of the effects of Ficoll-Hypaque separation
and whole blood lysis on results of immunophenotypic analysis of blood and bone marrow
samples from patients with hematologic malignancies. Clin Diagn Lab Immunol 1995;2:337–42.
[PubMed: 7545079]
Tiemessen CT, Shalekoff S, Meddows-Taylor S, Schramm DB, Papathanasopoulos MA, Gray GE,
Sherman GG, Coovadia AH, Kuhn L. Cutting Edge: Unusual NK cell responses to HIV-1 peptides
are associated with protection against maternal-infant transmission of HIV-1. J Immunol
2009;182:5914–8. [PubMed: 19414742]
Weinberg A, Song LY, Wilkening C, Sevin A, Blais B, Louzao R, Stein D, Defechereux P, Durand D,
Riedel E, Raftery N, Jesser R, Brown B, Keller MF, Dickover R, McFarland E, Fenton T.
Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for
functional and phenotypic T-cell characterization. Clin Vaccine Immunol 2009;16:1176–86.
[PubMed: 19515870]
Wong AH, Williams K, Reddy S, Wilson D, Giddy J, Alter G, Ghebremichael M, Carrington MN,
Ndung’u T, Walker BD, Altfeld M, Carr WH. Alterations in natural killer cell receptor profiles
during HIV type 1 disease progression among chronically infected South African adults. AIDS
Res Hum Retroviruses 26:459–69. [PubMed: 20380481]
Zhang Y, Wallace DL, de Lara CM, Ghattas H, Asquith B, Worth A, Griffin GE, Taylor GP, Tough
DF, Beverley PC, Macallan DC. In vivo kinetics of human natural killer cells: the effects of ageing
and acute and chronic viral infection. Immunology 2007;121:258–65. [PubMed: 17346281]
Ziegler SF, Ramsdell F, Hjerrild KA, Armitage RJ, Grabstein KH, Hennen KB, Farrah T, Fanslow
WC, Shevach EM, Alderson MR. Molecular characterization of the early activation antigen CD69:
a type II membrane glycoprotein related to a family of natural killer cell activation antigens. Eur J
Immunol 1993;23:1643–8. [PubMed: 8100776]
Naranbhai et al. Page 10













Fig 1. Study workflow
(A) Sample acquisition and processing time delays: A total of 34 mls of blood per individual
was collected from five healthy adult female volunteers. The blood samples were collected
into ACD tubes and subsequently processed at 2, 8,16 or 24 hrs after venipuncture.
Peripheral blood mononuclear cells (PBMC) prepared by density gradient centrifugation and
whole blood (WB) samples were surface stained with monoclonal antibodies, fixed and
analyzed on an LSRII multiparameter flow-cytometer at the DDMRI, Durban, South Africa.
(B) Gating strategy to define NK cell populations in PBMC (time, singlet, Live/CD14neg/
CD19neg, CD3neg, CD56pos and/or CD16pos). For the analysis of whole blood, CD45
staining was used to identify lymphocytes (CD45pos).
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Fig 2. Frequencies of NK cells are not affected by delays in blood sample processing (n=5)
Fig 2A shows the frequency of NK cells as a proportion of lymphocytes in PBMC processed
at 2, 8, 16 or 24 hrs (hrs) after venipuncture. The indicated p-value represents the result of a
paired t-test. Fig 2B shows the frequency of NK cells as a proportion of CD45pos
lymphocytes in whole blood processed at 2 or 24 hrs after venipuncture The indicated p-
value represents the result of repeated measures analysis of variance (ANOVA). A post-test
for linear trend gives p=0.031, r=0.312. Data shown represent means of duplicate measures
for each participant (n=5). Open shapes (○ ▽ △□) represent means of duplicate measures
from whole blood, closed shapes represent means of duplicate measures from PBMC
(■▼▲●); circles (● or ○), inverted triangles (▼ or ▽), upright triangles (▲ or △) and
squares (■ or □) represent measures of NK cell frequency at 2, 8, 16 and 24 hours
respectively, and as indicated. Each data point represents one individual.
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Fig 3. Density gradient centrifugation alters NK cell activationand the expression of chemokine
receptors (n=5)
Fig. 3A shows the proportion of NK cells expressing CD38, HLA-DR, CD69 or NKp46 in
whole blood (WB) and PBMC processed 2 hrs after venipuncture. Fig. 1B shows the
proportion of NK cells expressing CCR4 or CCR7 in WB and PBMC processed 2 hrs after
venipuncture. The indicated p-values represent the results of paired t-tests. Data shown in
Fig. 3A represent means of duplicate measures for each participant (n=5). Open shapes (○ ▽
△□) represent means of duplicate measures from whole blood, closed shapes represent
means of duplicate measures from PBMC (■▼▲●); circles (● or ○), inverted triangles (▼
or dtri;), upright triangles (▲ or △) and squares (■ or □) represent measures of NK cell
frequency at 2, 8, 16 and 24 hours respectively, and as indicated. Each data point represents
one individual.
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Fig 4. Delayed processing of blood alters NK cell activation and the expression of chemokine
receptors (n=5)
Fig. 4A shows the proportion of NK cells expressing CD38, HLA-DR, CD69 or NKp46 in
PBMC processed after 2, 8, 16 or 24 hrs after venipuncture. Fig 4B shows the proportion of
NK cells expressing CCR4 or CCR7 in PBMC processed after 2, 8, 16 or 24 hrs after
venipuncture. The indicted p-values in Fig. 4A and 4B represent the results of repeated
measures analysis of variance (ANOVA). Fig 4C shows the proportion of NK cells
expressing CD38, HLA-DR, CD69 or NKp46 in whole blood (WB) at 2 or 24 hrs after
venipuncture. Fig 4D shows the proportion of NK cells expressing CCR4 or CCR7 in WB at
2 or 24 hrs after venipuncture. The indicated p-values in Fig. 4C and 4D represent the results
of a paired t-test. Data shown in Fig. 4A and 4C represent means of duplicate measures for
each participant (n=5).Open shapes (○ ▽ △□) represent means of duplicate measures from
whole blood, closed shapes represent means of duplicate measures from PBMC (■▼▲●);
circles (● or ○), inverted triangles (▼ or ▽), upright triangles (▲ or △) and squares (■ or
□) represent measures of NK cell frequency at 2, 8, 16 and 24 hours respectively, and as
indicated. Each data point represents one individual.
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Fig 5. Delayed processing of blood decreases functional responses by NK cells as measured by
CD107a expression and cytokine secretion following in vitro stimulation (n=6)
Fig. 5 shows the proportion of NK cells expressing CD107a (a surrogate for degranulation),
interferon-γ (IFN-γ) or Tumour Necrosis Factor-α (TNF-α) in response to PMA/Ionomycin
stimulation ofPBMC processed at 2, 16 or 24 hrs after venipuncture. The indicted p-value
represents the results of repeated measures analysis of variance (ANOVA) (n=6). Circles,
triangles and squares (■▲●) represent the NK cell parameter as denoted on the x-axis label,
at 2, 16, and 24 hours respectively, and as indicated. Each data pointrepresents one
individual.
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